Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.

Authors

Joshua J Neumiller
Jay H Shubrook
Tom Manley
Radica Alicic, Providence Medical Research Center, Providence Health Care, Spokane, WAFollow
Katherine Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, WAFollow

Document Type

Article

Publication Date

1-1-2022

Publication Title

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Keywords

washington; spokane; Diabetes Mellitus, Type 2; Humans; Pharmacists; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors

Clinical Institute

Kidney & Diabetes

Department

Endocrinology

Department

Nephrology

Recommended Citation

Neumiller, Joshua J; Shubrook, Jay H; Manley, Tom; Alicic, Radica; and Tuttle, Katherine, "Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists." (2022). Articles, Abstracts, and Reports. 5781.
https://digitalcommons.providence.org/publications/5781